FlexLab Automation System used with the following Modules: High Volume Storage(P/N FLX-270, FLX-2...

FDA Device Recall #Z-2114-2020 — Class II — April 7, 2020

Recall Summary

Recall Number Z-2114-2020
Classification Class II — Moderate risk
Date Initiated April 7, 2020
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Inpeco S.A.
Location Lugano, N/A
Product Type Devices
Quantity 10 systems

Product Description

FlexLab Automation System used with the following Modules: High Volume Storage(P/N FLX-270, FLX-271, FLX-276, FLX-282, FLX-283), HSQ Interface Module (P/N FLX-274), Aliquoter Module (P/N FLX-209), Rack Output Module ROM400 (P/N FLX-289), XN-9000 Interface Module (P/N FLX-290), Advia 2120 LAS Interface Module (P/N FLX-219), Vertical Transportation Module (P/N FLX -204), Rack Input Module (P/N FLX-214), AUWi System Interface Module (P/N FLX-286), Track To Rack Interface Module (P/N FLX-295) - Product Usage: is a modular system designed to automate Pre-Analytical and Post-Analytical processing, sample handling in order to automate sample processing in the Laboratory. The systems consolidate multiple Analytical instruments into a unified workstation.

Reason for Recall

The sensors which activate the safety switches may be affected by delayed activation. In 1% of the cases, the response delay can be up to a maximum delay of 2 seconds, instead of 40ms expected by design.

Distribution Pattern

The products were distributed to the following US States: IL and NY.

Lot / Code Information

Serial Numbers: FLX.0133 FLX.0191 FLX.0192 FLX.0197 FLX.0198 FLX.0201 FLX.0202 FLX.027 FLX.0200 FLX.0181

Other Recalls from Inpeco S.A.

Recall # Classification Product Date
Z-0596-2026 Class II FlexLab (FLX); Version: FLX-217-40; Oct 30, 2025
Z-0595-2026 Class II FlexLab (FLX); Version: FLX-217-10; Oct 30, 2025
Z-0106-2026 Class II FlexLab (FLX) System. Potassium Test System. in... Sep 3, 2025
Z-0107-2026 Class II FlexLab X (FXX) System. Potassium Test System. ... Sep 3, 2025
Z-0560-2024 Class II Roche Cobas 8000 and Cobas PRO Interface Module... Nov 3, 2023

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.